| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0591-2729-01 | 0591-2729 | HUMAN PRESCRIPTION DRUG | Potassium Citrate | Potassium Citrate | TABLET, EXTENDED RELEASE | ORAL | 20180530 | N/A | ANDA | ANDA209758 | Actavis Pharma, Inc. | POTASSIUM CITRATE | 10 meq/1 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0591-2729-01) |
| 0591-2742-01 | 0591-2742 | HUMAN PRESCRIPTION DRUG | Potassium Citrate | Potassium Citrate | TABLET, EXTENDED RELEASE | ORAL | 20180530 | N/A | ANDA | ANDA209758 | Actavis Pharma, Inc. | POTASSIUM CITRATE | 15 meq/1 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0591-2742-01) |
| 63629-8759-1 | 63629-8759 | HUMAN PRESCRIPTION DRUG | Potassium Citrate | Potassium Citrate | TABLET, EXTENDED RELEASE | ORAL | 20220825 | N/A | ANDA | ANDA209758 | Bryant Ranch Prepack | POTASSIUM CITRATE | 10 meq/1 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-8759-1) |
| 0591-2682-01 | 0591-2682 | HUMAN PRESCRIPTION DRUG | Potassium Citrate | Potassium Citrate | TABLET, EXTENDED RELEASE | ORAL | 20180530 | N/A | ANDA | ANDA209758 | Actavis Pharma, Inc. | POTASSIUM CITRATE | 5 meq/1 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0591-2682-01) |